Annual Operating Profit
$597.58 M
+$85.31 M+16.65%
31 December 2023
Summary:
Jazz Pharmaceuticals annual operaing income is currently $597.58 million, with the most recent change of +$85.31 million (+16.65%) on 31 December 2023. During the last 3 years, it has risen by +$427.30 million (+250.94%). JAZZ annual operating profit is now -21.93% below its all-time high of $765.46 million, reached on 31 December 2020.JAZZ Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Operating Profit
$260.21 M
+$60.77 M+30.47%
30 September 2024
Summary:
Jazz Pharmaceuticals quarterly operating income is currently $260.21 million, with the most recent change of +$60.77 million (+30.47%) on 30 September 2024. Over the past year, it has increased by +$119.71 million (+85.21%). JAZZ quarterly operating profit is now at all-time high.JAZZ Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM Operating Profit
$676.36 M
+$87.82 M+14.92%
30 September 2024
Summary:
Jazz Pharmaceuticals TTM operating income is currently $676.36 million, with the most recent change of +$87.82 million (+14.92%) on 30 September 2024. Over the past year, it has increased by +$78.78 million (+13.18%). JAZZ TTM operating profit is now -13.16% below its all-time high of $778.87 million, reached on 31 March 2021.JAZZ TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
JAZZ Operating Profit Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +85.2% | +13.2% |
| 3 y3 years | +250.9% | +426.9% | +297.2% |
| 5 y5 years | -7.0% | +324.9% | +5.3% |
JAZZ Operating Profit High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | at high | +250.9% | at high | +426.9% | at high | +606.7% |
| 5 y | 5 years | -21.9% | +250.9% | at high | +473.9% | -13.2% | +606.7% |
| alltime | all time | -21.9% | +525.0% | at high | +333.9% | -13.2% | +453.6% |
Jazz Pharmaceuticals Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $260.21 M(+30.5%) | $676.36 M(+14.9%) |
| June 2024 | - | $199.44 M(+161.7%) | $588.54 M(+7.6%) |
| Mar 2024 | - | $76.21 M(-45.8%) | $546.73 M(-8.5%) |
| Dec 2023 | $597.58 M(+16.7%) | $140.50 M(-18.5%) | $597.58 M(+5.1%) |
| Sept 2023 | - | $172.39 M(+9.4%) | $568.70 M(+2.5%) |
| June 2023 | - | $157.64 M(+24.1%) | $554.72 M(+0.5%) |
| Mar 2023 | - | $127.06 M(+13.8%) | $551.77 M(+7.7%) |
| Dec 2022 | $512.27 M(+200.8%) | $111.61 M(-29.5%) | $512.27 M(+13.8%) |
| Sept 2022 | - | $158.41 M(+2.4%) | $450.03 M(+40.6%) |
| June 2022 | - | $154.69 M(+76.7%) | $319.99 M(+234.3%) |
| Mar 2022 | - | $87.55 M(+77.3%) | $95.71 M(-43.8%) |
| Dec 2021 | $170.28 M(-77.8%) | $49.38 M(+74.1%) | $170.28 M(-48.4%) |
| Sept 2021 | - | $28.37 M(-140.8%) | $330.31 M(-35.0%) |
| June 2021 | - | -$69.59 M(-142.9%) | $508.15 M(-34.8%) |
| Mar 2021 | - | $162.12 M(-22.6%) | $778.87 M(+1.8%) |
| Dec 2020 | $765.46 M(+19.2%) | $209.41 M(+1.6%) | $765.46 M(+24.0%) |
| Sept 2020 | - | $206.21 M(+2.5%) | $617.29 M(+3.6%) |
| June 2020 | - | $201.13 M(+35.2%) | $595.96 M(-0.9%) |
| Mar 2020 | - | $148.72 M(+142.8%) | $601.32 M(-6.4%) |
| Dec 2019 | $642.35 M(-2.3%) | $61.24 M(-66.9%) | $642.35 M(-16.2%) |
| Sept 2019 | - | $184.88 M(-10.5%) | $766.16 M(-0.5%) |
| June 2019 | - | $206.48 M(+8.8%) | $770.06 M(+1.4%) |
| Mar 2019 | - | $189.74 M(+2.5%) | $759.67 M(+15.5%) |
| Dec 2018 | $657.73 M(+7.2%) | $185.06 M(-2.0%) | $657.73 M(+5.8%) |
| Sept 2018 | - | $188.78 M(-3.7%) | $621.88 M(+4.6%) |
| June 2018 | - | $196.09 M(+123.3%) | $594.56 M(+5.1%) |
| Mar 2018 | - | $87.81 M(-41.2%) | $565.51 M(-7.9%) |
| Dec 2017 | $613.84 M(-0.3%) | $149.21 M(-7.6%) | $613.84 M(-2.6%) |
| Sept 2017 | - | $161.45 M(-3.3%) | $630.14 M(+1.6%) |
| June 2017 | - | $167.04 M(+22.7%) | $619.94 M(-0.3%) |
| Mar 2017 | - | $136.14 M(-17.7%) | $621.63 M(+1.0%) |
| Dec 2016 | $615.40 M(+14.0%) | $165.50 M(+9.4%) | $615.40 M(+4.7%) |
| Sept 2016 | - | $151.25 M(-10.4%) | $588.05 M(+3.5%) |
| June 2016 | - | $168.74 M(+29.9%) | $568.33 M(+2.8%) |
| Mar 2016 | - | $129.91 M(-6.0%) | $552.90 M(+2.4%) |
| Dec 2015 | $539.74 M(+23.3%) | $138.15 M(+5.0%) | $539.74 M(+0.2%) |
| Sept 2015 | - | $131.53 M(-14.2%) | $538.70 M(-0.3%) |
| June 2015 | - | $153.30 M(+31.3%) | $540.20 M(+9.4%) |
| Mar 2015 | - | $116.76 M(-14.8%) | $494.00 M(+12.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2014 | $437.58 M(+26.7%) | $137.10 M(+3.1%) | $437.58 M(+10.8%) |
| Sept 2014 | - | $133.04 M(+24.2%) | $394.97 M(+8.7%) |
| June 2014 | - | $107.10 M(+77.5%) | $363.49 M(+9.0%) |
| Mar 2014 | - | $60.34 M(-36.1%) | $333.45 M(-3.4%) |
| Dec 2013 | $345.30 M(+74.5%) | $94.50 M(-6.9%) | $345.30 M(+8.5%) |
| Sept 2013 | - | $101.55 M(+31.8%) | $318.18 M(+17.0%) |
| June 2013 | - | $77.07 M(+6.8%) | $271.93 M(+16.1%) |
| Mar 2013 | - | $72.19 M(+7.1%) | $234.29 M(+18.4%) |
| Dec 2012 | $197.84 M(+54.8%) | $67.38 M(+21.8%) | $197.84 M(+17.7%) |
| Sept 2012 | - | $55.30 M(+40.3%) | $168.13 M(+14.7%) |
| June 2012 | - | $39.43 M(+10.3%) | $146.53 M(+3.9%) |
| Mar 2012 | - | $35.74 M(-5.1%) | $140.97 M(+10.3%) |
| Dec 2011 | $127.83 M(+121.2%) | $37.66 M(+11.7%) | $127.83 M(+10.5%) |
| Sept 2011 | - | $33.70 M(-0.5%) | $115.70 M(+20.0%) |
| June 2011 | - | $33.86 M(+49.8%) | $96.44 M(+31.8%) |
| Mar 2011 | - | $22.60 M(-11.5%) | $73.16 M(+26.6%) |
| Dec 2010 | $57.79 M(+262.8%) | $25.54 M(+76.8%) | $57.79 M(+32.3%) |
| Sept 2010 | - | $14.44 M(+36.5%) | $43.66 M(+32.6%) |
| June 2010 | - | $10.58 M(+46.4%) | $32.93 M(+8.4%) |
| Mar 2010 | - | $7.23 M(-36.6%) | $30.38 M(+90.7%) |
| Dec 2009 | $15.93 M(-111.3%) | $11.41 M(+207.6%) | $15.93 M(-191.4%) |
| Sept 2009 | - | $3.71 M(-53.8%) | -$17.44 M(-64.3%) |
| June 2009 | - | $8.03 M(-211.2%) | -$48.89 M(-53.0%) |
| Mar 2009 | - | -$7.22 M(-67.1%) | -$104.02 M(-26.0%) |
| Dec 2008 | -$140.60 M(+1.3%) | -$21.96 M(-20.9%) | -$140.60 M(-20.7%) |
| Sept 2008 | - | -$27.74 M(-41.1%) | -$177.39 M(+5.9%) |
| June 2008 | - | -$47.09 M(+7.5%) | -$167.44 M(+2.7%) |
| Mar 2008 | - | -$43.81 M(-25.4%) | -$163.10 M(+17.5%) |
| Dec 2007 | -$138.78 M(+77.8%) | -$58.74 M(+230.1%) | -$138.78 M(-27.4%) |
| Sept 2007 | - | -$17.80 M(-58.4%) | -$191.27 M(+18.2%) |
| June 2007 | - | -$42.75 M(+119.4%) | -$161.80 M(+50.7%) |
| Mar 2007 | - | -$19.48 M(-82.5%) | -$107.37 M(+37.6%) |
| Dec 2006 | -$78.05 M(+36.6%) | -$111.23 M(-1052.9%) | -$78.05 M(+94.9%) |
| Sept 2006 | - | $11.67 M(0.0%) | -$40.04 M(-13.6%) |
| June 2006 | - | $11.67 M(+18.7%) | -$46.35 M(-12.0%) |
| Mar 2006 | - | $9.84 M(-113.4%) | -$52.67 M(-7.8%) |
| Dec 2005 | -$57.14 M | -$73.23 M(-1465.9%) | -$57.14 M(-455.3%) |
| Sept 2005 | - | $5.36 M(0.0%) | $16.08 M(+50.0%) |
| June 2005 | - | $5.36 M(0.0%) | $10.72 M(+100.0%) |
| Mar 2005 | - | $5.36 M | $5.36 M |
FAQ
- What is Jazz Pharmaceuticals annual operaing income?
- What is the all time high annual operating profit for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals quarterly operating income?
- What is the all time high quarterly operating profit for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals quarterly operating profit year-on-year change?
- What is Jazz Pharmaceuticals TTM operating income?
- What is the all time high TTM operating profit for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals TTM operating profit year-on-year change?
What is Jazz Pharmaceuticals annual operaing income?
The current annual operating profit of JAZZ is $597.58 M
What is the all time high annual operating profit for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high annual operaing income is $765.46 M
What is Jazz Pharmaceuticals quarterly operating income?
The current quarterly operating profit of JAZZ is $260.21 M
What is the all time high quarterly operating profit for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high quarterly operating income is $260.21 M
What is Jazz Pharmaceuticals quarterly operating profit year-on-year change?
Over the past year, JAZZ quarterly operating income has changed by +$119.71 M (+85.21%)
What is Jazz Pharmaceuticals TTM operating income?
The current TTM operating profit of JAZZ is $676.36 M
What is the all time high TTM operating profit for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high TTM operating income is $778.87 M
What is Jazz Pharmaceuticals TTM operating profit year-on-year change?
Over the past year, JAZZ TTM operating income has changed by +$78.78 M (+13.18%)